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Soft tissue injury and defects from disease or trauma, present critical
challenges in repair and regeneration. Soft tissue engineering aims at
replacing or repairing these injury and defects via a combined approach of
biodegradable scaffolds, suitable cell sources and appropriate biological
environment, such as biomolecules presented and sustainably released on
scaffold surfaces. Soft tissue engineering strategies targeting on the
restoration of tissue loss have inherent critical challenges as they relate to
the problem of restoration of defects with a high volume to surface ratio.
There are problems associated with the limitations of translational ap-
plications regarding soft tissue engineering strategies such as cell survival,
macroenvironment, microenvironment, and cell migration. This workshop
provides a brief overview of the various drugs, bioactive molecules,
and scaffolds and matrices of interest to ligament tissue engineering.
Recent advances in encapsulation, immobilization and controlled release
strategies for bioactive proteins focuses in soft tissue engineering.
Minimal clinical success has been achieved so far in using growth factor,
morphogen, or adhesion factor modified scaffolds and matrices. Only one
growth factor delivery system has been approved by the FDA for clinical
use, with only a few of other growth factors being approved for human
use. Some more growth factors are currently in clinical Phase IeII ori.org/10.1016/j.jot.2016.06.016preclinical trials and some delivery systems utilize biomedical materials
have been approved for other purposes. With respect to drug delivery in
soft tissue engineering, a combination of hydrogel, biological material and
growth factor development is needed for clinical application. The induc-
tion and evaluation strategies in tendinopathy and the effects of me-
chanical stimulation on ligament and tendon will be discussed in the
workshop.
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